Trust Signals
Reviewed by: FormBlends Medical Team, May 29, 2026. This page cites FDA, USP, WADA, and peer-reviewed pharmacology. Claims are graded by evidence level. No sponsored rankings. No affiliate links. Red flags are named plainly.Key Takeaways
- Sermorelin acetate is a 29-amino-acid GHRH analog that requires a valid US physician prescription. Any vendor selling it without one is outside FDA regulations.
- The strongest evidence for sermorelin is in diagnosed pediatric GH deficiency (FDA-approved 1997). Adult anti-aging use is off-label and supported largely by mechanistic and small open-label data.
- 503B outsourcing facilities are held to cGMP batch-testing standards by the FDA; 503A pharmacies are state-regulated. Both are legal, but the testing rigor differs meaningfully.
- WADA prohibits sermorelin for athletes both in and out of competition as a GH-releasing peptide/factor.
- IGF-1 is the accepted clinical surrogate for GH axis activity. A prescriber who never orders it before or during treatment is not following accepted clinical practice.
Direct Answer (40-60 words)
The best place to get sermorelin is through a licensed US telehealth clinic that orders baseline labs, uses a 503A or 503B US compounding pharmacy, and provides an actual physician consultation before prescribing. Options like Defy Medical, Maximus, and TRT Nation follow this model. Avoid any vendor that ships without a prescription or skips IGF-1 testing.Table of Contents
- The legal landscape: what sermorelin actually is and who can prescribe it
- Best places to get sermorelin: the ranked list with honest caveats
- Evidence ledger: what the research actually supports
- Mechanism with numbers: how sermorelin works and what that proves
- What most pages get wrong about sourcing sermorelin
- Honest head-to-head: sermorelin vs. alternatives
- COA and label literacy: how to vet your pharmacy
- Red flags checklist: how to spot an illegitimate source
- Dosing and monitoring table
- FAQ
What Is Sermorelin and Who Can Legally Prescribe It?
Sermorelin acetate is a synthetic 29-amino-acid peptide corresponding to the N-terminal fragment of endogenous human growth hormone-releasing hormone (GHRH 1-29). The FDA approved it as Geref (Serono) in 1997 for treatment of idiopathic growth hormone deficiency in children. The branded product was voluntarily withdrawn from the US market around 2008 for commercial reasons, not safety. Since then, it has been legally available only through compounding pharmacies under a valid prescription.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Sermorelin is not a controlled substance under the Controlled Substances Act. It is, however, a prescription drug. A licensed physician (MD or DO), or in some states an NP or PA with prescriptive authority, must evaluate the patient, determine clinical appropriateness, and write a prescription to a licensed US compounding pharmacy. The compounding pharmacy dispenses it; the prescriber does not legally sell it directly.
Best Places to Get Sermorelin: The Ranked List
These are the main categories, not paid rankings. Within each category, examples are named where they are publicly known. Ranking is based on published process transparency, pharmacy sourcing standards, and clinical protocol rigor.
1. Licensed Telehealth Hormone Clinics Best Overall
Examples: Defy Medical, Maximus, TRT Nation, Evolve Telemed, AgelessRx.
Why they lead: These clinics require a physician or NP consultation (synchronous or asynchronous depending on state), order baseline labs including IGF-1 before prescribing, and dispense only from licensed US compounding pharmacies. Most have in-house or affiliated 503A pharmacies and some use 503B outsourcing facilities.
Honest caveats: Quality varies significantly between providers. Some optimize for volume and use short asynchronous questionnaires rather than real consultations. Ask explicitly which pharmacy is used and whether it is 503A or 503B before paying. Cost typically ranges from roughly $150 to $350 per month all-in for sermorelin, though prices shift frequently.
Best for: Adults who want a compliant, monitored protocol without traveling to a physical clinic.
2. In-Person Anti-Aging or Functional Medicine Clinics Strong, Higher Cost
Examples: Cenegenics, local functional medicine MDs, integrative endocrinologists.
Why they are strong: In-person consultations allow a more thorough physical exam and history. A pituitary MRI is more likely to be ordered if clinically appropriate. The physician relationship is generally more robust than a purely online interaction.
Honest caveats: Cost is substantially higher, often $300 to $600 or more per month when clinic fees and pharmacy costs are combined. Geographic access is uneven. The clinical rigor varies as much as with telehealth: a medspa with a supervising MD signing scripts remotely offers no advantage over telehealth and possibly less oversight.
Best for: Patients with complex histories, prior pituitary pathology, or who prefer face-to-face care.
3. Direct-to-Consumer Telehealth Platforms with Lab Integration Emerging, Verify Carefully
Examples: Some newer platforms (Fountain, Hone Health, others) have added peptide protocols including sermorelin.
Why they are relevant: Competitive pricing, streamlined lab ordering, and app-based monitoring are genuine conveniences. Some integrate with LabCorp or Quest for baseline draws.
Honest caveats: This is the highest-variance category. Some newer platforms prescribe peptides after a brief questionnaire with minimal real clinical review. Verify that a licensed physician (not just a wellness coach or NP under loose supervision) reviews your labs and history. Confirm the pharmacy is US-licensed and compounding-compliant.
Best for: Cost-conscious, tech-comfortable users who are willing to do due diligence on the backend pharmacy.
4. Your Own Primary Care Physician or Endocrinologist Ideal If Available
Why it is ideal: Your existing physician knows your full history. An endocrinologist can formally assess GH axis function, order stimulation testing if indicated, and prescribe sermorelin to a local licensed compounding pharmacy. This is the most evidence-consistent pathway.
Honest caveats: Most primary care physicians will not prescribe sermorelin off-label for adult wellness, and most endocrinologists reserve GH-axis treatment for formally diagnosed GH deficiency. This route is more realistic for patients with documented hypopituitarism or post-traumatic GH deficiency than for healthy adults seeking performance or anti-aging effects.
Best for: Patients with a genuine clinical indication and an open-minded specialist.
5. "Research Peptide" Websites Do Not Use for Human Administration
These vendors sell sermorelin labeled "for research use only" without requiring a prescription. Under US federal law, this labeling does not make it legal for human use. Purity and sterility are unverified by any regulated body. Some independent analyses of research-grade peptides have found significant potency variance and contamination risk. This is not a legitimate clinical option and is not ranked as one.
Evidence Ledger: What the Research Actually Supports
| Claim | Best Evidence Type | Effect Direction | Confidence |
|---|---|---|---|
| Sermorelin increases GH secretion in children with idiopathic GH deficiency | Human RCTs, FDA registration trials (pediatric) | Positive, clinically meaningful | High |
| Sermorelin raises IGF-1 in GH-deficient adults | Small open-label human studies | Positive, magnitude varies | Moderate |
| Sermorelin improves body composition (lean mass, fat mass) in healthy aging adults | Mechanistic inference, small open-label series; no large adult RCT | Directionally positive, unproven at scale | Low |
| Sermorelin improves sleep quality | Mechanistic (GH peaks during slow-wave sleep); very limited direct human data | Plausible, not proven | Very Low |
| Sermorelin preserves pulsatile GH feedback vs. exogenous GH | Pharmacodynamic studies, mechanistic data | Positive vs. direct GH | Moderate |
| Sermorelin is safe at standard compounded doses in adults over months | Post-market case series, clinical practice data; no long-duration RCT in adults | Favorable short-term safety signal | Moderate (short-term) |
Mechanism With Numbers: How Sermorelin Works and What That Does Not Prove
Sermorelin binds to the GHRH receptor (GHRHR), a Gs-coupled GPCR expressed on pituitary somatotroph cells. Receptor binding activates adenylyl cyclase, raises intracellular cAMP, and triggers pulsatile GH release. The 29-amino-acid sequence of sermorelin is the minimum active fragment needed for full GHRHR binding and signaling; full-length GHRH is 44 amino acids, so sermorelin retains roughly the first two-thirds of the molecule.
Subcutaneous sermorelin has a reported plasma half-life of roughly 10 to 20 minutes in humans, reflecting rapid proteolytic degradation by dipeptidylpeptidase IV and other serum peptidases. This short half-life means it mimics the physiologic pulsatility of endogenous GHRH, unlike CJC-1295 with DAC, which has a half-life extending to days via albumin binding.
What the mechanism does NOT prove: The fact that sermorelin raises GH and IGF-1 does not prove it produces the body composition or longevity outcomes associated with GH deficiency reversal in clinical disease. GH axis physiology in aging differs from GH deficiency pathology. The mechanism is real; the outcome evidence in healthy adults is thin.
What Most Pages Get Wrong About Sourcing Sermorelin
1. Treating 503A and 503B as equivalent. Most medspa content describes "compounding pharmacy" as a single category. The distinction matters. 503B outsourcing facilities are registered with the FDA, inspected under cGMP standards, and required to perform sterility and potency testing on each production lot (USP 71 sterility, USP 85 endotoxin). A 503A pharmacy compounds per individual prescription and is subject to state board oversight, which varies significantly by state. Neither is inherently unsafe, but a 503B COA carries more regulatory weight. Ask your telehealth provider which type of facility fills your prescription.
2. Ignoring the stability reality. Lyophilized (freeze-dried) sermorelin powder is reasonably stable refrigerated. Once reconstituted in bacteriostatic water, stability declines over weeks, especially with temperature fluctuations. The reconstituted peptide bond is vulnerable to hydrolysis and oxidation. Most protocols instruct use within 30 days of reconstitution and refrigeration throughout. Leaving reconstituted sermorelin at room temperature for extended periods or near a window degrades the product. Commodity pages say "store cold" without explaining that the peptide-water environment accelerates the same degradation reactions that body fluids cause, just more slowly.
3. Conflating sermorelin with ipamorelin or CJC-1295/ipamorelin combinations. Many telehealth providers now prescribe CJC-1295 with ipamorelin rather than sermorelin alone. These are different mechanisms (GHRH analog plus ghrelin mimetic). A page claiming to help you "get sermorelin" should be honest if the protocol has shifted to combination products. The evidence bases are entirely different.
Honest Head-to-Head: Sermorelin vs. Alternatives
| Compound | FDA Status | Strongest Evidence | Half-Life | Where Sermorelin Wins | Where Sermorelin Loses |
|---|---|---|---|---|---|
| Sermorelin | Approved (pediatric), off-label adult use via compounding | Pediatric GH deficiency RCTs | ~10-20 min | Preserves pulsatility, long safety record vs. research peptides | No adult RCT for body composition or longevity outcomes |
| Tesamorelin | FDA-approved (Egrifta) for HIV lipodystrophy | Multiple RCTs in HIV patients; body fat reduction well-documented | ~26 min | Loses here: tesamorelin has stronger adult human RCT evidence | Higher cost, narrower approved indication, less available via compounding |
| Exogenous recombinant GH (somatropin) | FDA-approved for multiple indications | Extensive RCT data for approved indications | ~2-4 hours | Sermorelin preserves feedback loops, lower suppression risk in theory | GH itself has more proven efficacy data; sermorelin is the weaker option if GH deficiency is formally diagnosed |
| CJC-1295 (no DAC) with Ipamorelin | Not FDA-approved; compounded off-label | Animal and mechanistic data; minimal human RCT data | CJC-1295 ~30 min; ipamorelin ~2 h | Sermorelin has longer human safety history and prior FDA approval | Combination may produce larger GH pulse via dual mechanism; neither is proven in adults |
| MK-677 (ibutamoren) | Not FDA-approved; investigational | Some human studies showing IGF-1 elevation; not conclusive on outcomes | ~6 hours (oral) | Sermorelin is injectable with shorter regulatory risk profile | MK-677 is oral, which patients prefer; no prescription required in some markets (not a safety advantage) |
COA and Label Literacy: How to Vet Your Compounding Pharmacy
A certificate of analysis (COA) is the document that proves a compounded batch was tested. Any reputable 503A or 503B pharmacy should provide one on request. Here is what to look for and what it means:
| COA Element | What to Look For | What It Means If Missing |
|---|---|---|
| Identity test (HPLC or mass spectrometry) | Confirmation that the molecule is sermorelin acetate, not a related or substitute peptide | You cannot confirm you received the labeled compound |
| Potency (% of label claim) | Should be within a reasonable range of stated concentration, often 90 to 110 percent by USP standards | Dosing accuracy is unknown; you may be over- or underdosing |
| Sterility (USP 71) | "Passes sterility testing" with the testing date | Injection risk; batch sterility unverified |
| Endotoxin (USP 85) | Below the limit of quantitation for an injectable product | Risk of fever, injection-site inflammation, systemic reaction |
| pH | Typically in the physiologic range for subcutaneous injection | Injection-site irritation increases outside normal range |
| Testing laboratory | Independent, accredited lab (not the compounder's own in-house lab for key safety tests) | Conflict of interest in self-reported results |
Reconstitution note: Most compounded sermorelin arrives as lyophilized powder in a multi-dose vial. Bacteriostatic water (0.9% benzyl alcohol) is the standard diluent. Sterile water is not appropriate for multi-dose vials because it lacks preservative. Add the diluent gently along the vial wall; do not shake (agitation can disrupt the peptide structure). The resulting solution is typically clear and colorless. Cloudiness, visible particles, or color change are signs of degradation or contamination; discard the vial.
Red Flags Checklist: How to Spot an Illegitimate Source
- No prescription required. Full stop. There is no legal pathway to dispense injectable sermorelin in the US without one.
- No lab work required before prescribing. A prescriber who does not check IGF-1 and metabolic baseline is not practicing standard care.
- Pharmacy is not named or is outside the US. Some telehealth operations use offshore compounders not subject to FDA or state board oversight.
- Price far below market. Legitimate US compounding with proper sterility testing has a floor cost. Prices well below $100 per month for a full injectable protocol should prompt questions about pharmacy sourcing.
- Claims of "FDA-approved sermorelin" for anti-aging. The FDA approval is for pediatric GH deficiency. Adult anti-aging use is off-label. Any marketing claiming FDA approval for wellness is misleading.
- No monitoring or follow-up built into the protocol. A legitimate prescriber schedules IGF-1 re-testing after several weeks of treatment to assess response and adjust dosing.
- "Peptide bundles" with no clinical rationale. Combining sermorelin with BPC-157, TB-500, and five other peptides in a single purchase package without individual clinical justification is a commercial sales pattern, not a clinical protocol.
Dosing and Monitoring: A Reference Table
| Parameter | Typical Adult Protocol (Off-Label) | Clinical Rationale |
|---|---|---|
| Starting dose | 100 to 200 mcg subcutaneous, at bedtime | Bedtime timing aligns with physiologic GH pulse during slow-wave sleep |
| Maximum commonly used dose | 300 mcg per night | Higher doses are used in some protocols but lack controlled adult safety data |
| Frequency | Daily or 5 days on, 2 days off | Days-off protocol theorized to limit receptor desensitization; not proven in human RCT |
| Baseline labs | IGF-1, CMP, fasting glucose, HbA1c | Screen for metabolic contraindications; establish IGF-1 baseline |
| Follow-up IGF-1 | 6 to 8 weeks after starting | Confirm response; adjust dose or discontinue if no IGF-1 movement |
| Target IGF-1 | Age-appropriate normal range, not supraphysiologic | Supraphysiologic IGF-1 carries theoretical oncologic risk; avoid pushing above normal |
| Typical protocol duration | 3 to 6 months, then reassess | No long-duration adult safety data; ongoing need should be justified by labs and symptoms |
Frequently Asked Questions
Is sermorelin legal to prescribe in the United States?
Yes. Sermorelin acetate is an FDA-approved drug (Geref, approved 1997 for pediatric GH deficiency) that is also legally compounded for adults by 503A and 503B pharmacies under a valid physician prescription. It is not a controlled substance.
Can I buy sermorelin without a prescription?
No legitimate route exists in the US. Any website selling sermorelin without requiring a prescription is operating outside FDA regulations. Products labeled "research use only" are not legal for human administration.
What is the difference between a 503A and 503B compounding pharmacy for sermorelin?
503A pharmacies compound on a per-patient, prescription-specific basis and are state-licensed. 503B outsourcing facilities produce larger batches, operate under FDA oversight, and must meet cGMP standards, making sterility testing more rigorous.
What labs should be ordered before starting sermorelin?
A responsible prescriber will check IGF-1, a comprehensive metabolic panel, fasting glucose, HbA1c, and a review of pituitary and CNS history. Some also order a baseline pituitary MRI if there is clinical suspicion for a mass.
How does sermorelin compare to tesamorelin or CJC-1295?
Tesamorelin has an FDA-approved indication for HIV-associated lipodystrophy and carries the strongest human RCT evidence. CJC-1295 is not FDA-approved and lacks controlled human trials. Sermorelin sits in between: approved but used off-label for adult GH deficiency.
What dose of sermorelin is typically prescribed?
Common adult compounded protocols range from 100 mcg to 300 mcg injected subcutaneously at bedtime, though dosing varies by individual IGF-1 response and physician judgment. Pediatric dosing used in pivotal trials was weight-based and is not directly applicable to adult protocols.
What are the main side effects of sermorelin?
The most commonly reported side effects are injection-site reactions (redness, swelling), transient facial flushing, and headache. Because sermorelin stimulates endogenous GH, it can cause water retention, joint discomfort, and mild elevations in fasting glucose at higher doses.
How long does it take for sermorelin to show results?
IGF-1 levels may begin to rise within weeks of starting treatment. Subjective improvements in sleep quality are often reported first. Body composition changes, if they occur, typically require three to six months of consistent use. Evidence for hard endpoints like lean mass in healthy adults is limited.
Does sermorelin suppress the body's own GH production?
Unlike direct GH administration, sermorelin works through the endogenous GHRH receptor and preserves physiologic pulsatility and feedback loops. Somatostatin-mediated negative feedback remains intact, which is why it is considered to have a lower suppression risk than exogenous GH, though long-term human data on axis suppression are limited.
What should a COA for compounded sermorelin show?
A legitimate COA should show identity confirmation (HPLC or mass spectrometry), potency within a stated range of label claim, sterility testing (USP 71), endotoxin testing (USP 85), and pH. The testing lab should be accredited and independent from the compounder.
Is sermorelin on the WADA prohibited list?
Yes. WADA prohibits all peptide hormones and releasing factors that stimulate GH secretion, including sermorelin, in competition and out of competition. Athletes subject to anti-doping rules should not use it.
What makes a telehealth sermorelin provider legitimate versus a red flag?
Legitimate providers require a synchronous consultation (video or phone) with a licensed physician or NP, order baseline labs before prescribing, dispense only from licensed US compounding pharmacies, and provide ongoing monitoring. Red flags include no lab requirement, flat-rate "wellness packages" dispensed without a real clinical evaluation, and prescriptions issued by non-US providers.
Sources
- US Food and Drug Administration. Geref (sermorelin acetate) prescribing information. FDA drug label archive. Originally approved 1997.
- US Food and Drug Administration. Human Drug Compounding: 503A and 503B distinctions. FDA.gov guidance documents.
- US Pharmacopeia. USP 71 Sterility Tests; USP 85 Bacterial Endotoxins Test. USP-NF online.
- World Anti-Doping Agency. 2024 Prohibited List. S2: Peptide Hormones, Growth Factors, Related Substances and Mimetics. WADA.ama.org.
- Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology and Metabolism. 2006;91(3):799-805.
- Falutz J, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. New England Journal of Medicine. 2007;357(23):2359-2370. (Tesamorelin pivotal trial.)
- Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocrine Reviews. 1993;14(1):20-39. (Mechanistic and clinical review of GHRH and aging.)
- Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. Journal of Clinical Endocrinology and Metabolism. 2006;91(12):4792-4797.
- Sigalos JT, Pastuszak AW. The safety and efficacy of growth hormone secretagogues. Sexual Medicine Reviews. 2018;6(1):45-53.
- Drug Enforcement Administration. Schedules of Controlled Substances. 21 CFR Part 1
Related peptide guides